Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 6
2006 3
2008 10
2009 8
2010 5
2011 5
2012 10
2013 6
2014 17
2015 8
2016 22
2017 18
2018 17
2019 18
2020 28
2021 23
2022 23
2023 16
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8. N Engl J Med. 2017. PMID: 28885881 Free article. Clinical Trial.
CCL4 Signaling in the Tumor Microenvironment.
Mukaida N, Sasaki SI, Baba T. Mukaida N, et al. Among authors: baba t. Adv Exp Med Biol. 2020;1231:23-32. doi: 10.1007/978-3-030-36667-4_3. Adv Exp Med Biol. 2020. PMID: 32060843 Review.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280658 Free article. Clinical Trial.
Quantitative Analysis for Lung Disease on Thin-Section CT.
Iwasawa T, Matsushita S, Hirayama M, Baba T, Ogura T. Iwasawa T, et al. Among authors: baba t. Diagnostics (Basel). 2023 Sep 18;13(18):2988. doi: 10.3390/diagnostics13182988. Diagnostics (Basel). 2023. PMID: 37761355 Free PMC article. Review.
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
Trapnell BC, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, Campo I, Papiris SA, Yamaguchi E, Cetinkaya E, Ilkovich MM, Kramer MR, Veltkamp M, Kreuter M, Baba T, Ganslandt C, Tarnow I, Waterer G, Jouhikainen T; IMPALA Trial Investigators. Trapnell BC, et al. Among authors: baba t. N Engl J Med. 2020 Oct 22;383(17):1635-1644. doi: 10.1056/NEJMoa1913590. Epub 2020 Sep 7. N Engl J Med. 2020. PMID: 32897035 Free PMC article. Clinical Trial.
Chemokines in tumor development and progression.
Mukaida N, Baba T. Mukaida N, et al. Among authors: baba t. Exp Cell Res. 2012 Jan 15;318(2):95-102. doi: 10.1016/j.yexcr.2011.10.012. Epub 2011 Oct 21. Exp Cell Res. 2012. PMID: 22036649 Free article. Review.
225 results